Skip to main content
David Gorelick, MD, Psychiatry, Baltimore, MD

DavidA.GorelickMD

Psychiatry • Baltimore, MD

Addiction

Professor of Psychiatry, University of Maryland School of Medicine Editor-in-Chief, Journal of Cannabis Research

Join to view full profile

Dr. Gorelick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gorelick's full profile

Already have an account?

Summary

  • David Gorelick, MD is a psychiatrist based in Baltimore, MD with a subspecialty in addiction. His medical training was completed at the Albert Einstein College of Medicine and residency at the UCLA David Geffen School of Medicine/UCLA Medical Center. He currently serves as a professor at the University of Maryland School of Medicine, editor-in-chief of the Journal of Cannabis Research, and a member of the Maryland Cannabis Public Health Advisory Council. Dr. Gorelick has published more than 200 papers in peer-reviewed medical journals and has designed and conducted numerous phase I and II clinical trials related to addiction and its treatmt. His work focuses on treatment of substance use disorders and comorbidity with other psychiatric disorders, such as schizophrenia.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1977 - 1980
  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1976 - 1977
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1977 - 2025
  • MD State Medical License
    MD State Medical License 1989 - 2024
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Legalization of Marijuana Could Lead to Public Health Concerns, Study Suggests
    Legalization of Marijuana Could Lead to Public Health Concerns, Study SuggestsJanuary 1st, 2020
  • Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
    Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid DependenceJuly 27th, 2006
  • Stop Smoking Now!! See the 9 Side Effects of Marijuana
    Stop Smoking Now!! See the 9 Side Effects of MarijuanaFebruary 25th, 2017
  • Join now to see all

Grant Support

  • Identification Of Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse2009–2010
  • Development Of New Pharmacologic And Biologic Treatments For Drug DependenceNational Institute On Drug Abuse2009–2010
  • Development Of New Pharmacologic And Biologic Treatments For Drug DependenceNational Institute On Drug Abuse2007–2008
  • Identification Of Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse1993–2008
  • Development Of New Pharmacologic And Biologic TreatmentsNational Institute On Drug Abuse2006
  • Identification Of Factors Associated With Response To DRNational Institute On Drug Abuse2002–2006
  • Identification Of Factor Associated W/ Response To DrugsNational Institute On Drug Abuse2005
  • Development Of New Pharmacologic And Biologic TreatmentsNational Institute On Drug Abuse2003–2005
  • Development Of New Pharmacologic And Biologic TreatmentNational Institute On Drug Abuse2002
  • New Treatment For Drug DependenceNational Institute On Drug Abuse2001
  • Factors Associated With Response To Drugs And TreatmentNational Institute On Drug Abuse2001
  • Development Of New Pharmacologic And Biologic Treatment For Drug DependenceNational Institute On Drug Abuse1993–2000

Professional Memberships

Dr. David Gorelick, Dr. David Gorelick, MD, Dr. D Gorelick, Dr. David A. Gorelick